21.86 USD
NAV Per Share
Exchange Traded Funds (ETF)
Type of fund
Equity
Investment category
Biotech
Sector
USA
Investor locations
11/06/2021
Inception Date
32.13 mln USD
Total assets of the fund
0.19 %
Total Cost Ratio
Nasdaq Biotechnology Index
Benchmark
Invesco
Provider
32.13 mln USD
Stock class assets
4 times per year
Dividend payments
-
Replication method
-
Minimum entry threshold
-
Split
US46138G5999
ISIN
IBBQ
Ticker
CEOJLS
CFI